Data / Form D filings / Evia Bio, Inc.
Evia Bio, Inc.: Form D filing
Evia Bio, Inc., a biotechnology company in Minneapolis, MN, filed a Form D with the SEC in 2026. The latest, on September 28, 2026, reports $5.5 million sold of a $5.5 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2001 6th Street SE, Room 2-434 Bench 33, Minneapolis, MN, 55455
- Phone
- (414) 852-0037
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1954759
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | New notice | $5,453,532 | $5,453,532 | 19 | Sep 14, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey Allen | Executive Officer, Director | |
| Marc Centrella | Director | |
| Scott Fisher | Director | |
| Allison Hubel | Director | |
| Troy Wichterman | Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Sep 28, 2026 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Evia Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.